Abstract Objective To investigate the effect of caffeine citrate treatment on early pulmonary function in preterm infants with apnea. Methods Forty preterm infants with apnea were randomly divided into aminophylline treatment group (20 infants) and caffeine citrate treatment group (20 infants). When the preterm infants experienced apnea after birth, they were given aminophylline or caffeine citrate in addition to assisted ventilation with continuous positive airway pressure (NCPAP). After drug discontinuation, pulmonary function was measured and compared between the two groups. Results After treatment, compared with the aminophylline treatment group, the caffeine citrate treatment group had significantly higher tidal volume, minute ventilation volume, ratio of time to peak tidal expiratory flow to total expiratory time, ratio of volume to peak tidal expiratory flow to total expiratory volume, peak expiratory flow, and breathing flow at 75%, 50%, and 25% of tidal volume (PPPConclusions In the treatment of apnea in preterm infants, caffeine citrate can improve early pulmonary function and reduce the incidence of apnea.
YU Mei,HUANG Jin-Hua,ZHU Rong et al. Effect of caffeine citrate on early pulmonary function in preterm infants with apnea[J]. CJCP, 2016, 18(3): 206-210.
YU Mei,HUANG Jin-Hua,ZHU Rong et al. Effect of caffeine citrate on early pulmonary function in preterm infants with apnea[J]. CJCP, 2016, 18(3): 206-210.
Hjalmarson O, Sandberg K. Abnormal lung function in healthy preterm infants[J]. Am J Respir Crit Care Med, 2002, 165(1): 83-87.
[2]
Mello RR, Silva KS, Costa AM, et al. Longitudinal assessment of the lung mechanics of very low birth weight preterm infants with and without bronchopulmonary dysplasia[J]. Sao Paulo Med J, 2015, 133(5): 401-407.
[3]
Francart SJ, Allen MK, Stegall-Zanation J. Apnea of prematurity: caffeine dose optimization[J]. Pediatr Pharmacol Ther, 2013, 18(1): 45-52.
[4]
Butcher-Puech MC, Henderson-Smart DJ, Holley D, et al. Relation between apnoea duration and type and neurological status of preterm infants[J]. Arch Dis Child, 1985, 60(10): 953-958.
[5]
ClinicalTrials.gov. Caffeine to reduce mechanical ventilation in preterm infants[DB/OL]. [February 3, 2014].
[6]
Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity[J]. N Engl J Med, 2007, 357(19): 1893-1902.
[7]
Schmidt B, Anderson PJ, Doyle LW. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity[J]. JAMA, 2012, 307(3): 275-282.
Kraaijenga JV, Hutten GJ, de Jongh FH, et al. The effect of Caffeine on diaphrabmatic activity and tidal volume in preterm infants [J]. J Pediatr, 2015, 167(1): 70-75.
[12]
Vatlach S, Arand J, Engel C, et a1. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity[J]. Neonatology, 2013, 105(2): 108-111.
[13]
Erenberg A1, Leff RD, Haack DG, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebocontrolled study[J]. Pharmacotherapy, 2000, 20(6): 644-652.
Laughon MM, Langer JC, Bose CL, et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants[J]. Am J Respir Crit Care Med, 2011, 183(12): 1715-1722.
[16]
Davis JM1, Bhutani VK, Stefano JL, et al. Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia [J]. Pediatr Pulmonol, 1989, 6(1): 49-52.
[17]
Marcus CL, Meltzer LJ, Roberts RS, et al. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age[ J]. Am J Respir Crit Care Med, 2014, 190(7): 791-799.
[18]
Poets CF, Khan SR. Former preterm infants, caffeine was good for you, but now beware of snoring![M]. Am J Respir Crit Care Med, 2014, 190(7): 720-721.
